OTC 프로바이오틱스 보충제 시장 예측(2025-2030년)

The OTC Probiotics Supplement Market, valued at US$16.953 billion in 2025, is projected to grow at a CAGR of 9.78%, reaching a market size of US$27.029 billion by 2030.

The market for OTC probiotics supplements is driven by rising health awareness among individuals, leading to the popularity of probiotic supplements. In addition, the expanding scope of probiotics application is anticipated to boost the demand in the coming years. Furthermore, there is a favorable outlook of people toward medical nutrition in developed countries like the United States and Germany, among others, due to an increased focus on immunity and mental health, which is driving market expansion. Moreover, OTC probiotics' easy availability and convenience are propelling the market growth.

Market Trends:

• Expanding Applications Create Growth Opportunities for Manufacturers and Vendors: With increasing research and development efforts, the potential applications of probiotics are expected to broaden during the forecast period. OTC pharmaceutical probiotics may soon replace other pharmaceutical agents. The market is poised for exponential growth as consumer awareness of the health benefits of probiotics rises. Additionally, the introduction of advanced and new flavored probiotic products, along with the growing popularity of OTC pharmaceutical probiotics, is expected to further expand growth opportunities for manufacturers and vendors.
• Rising Demand for Innovative and Convenient Probiotic Formats: There is a growing preference for convenient probiotic delivery formats such as gummies, chewables, and powders, driving a shift toward more user-friendly options.
• Asia-Pacific Growth: The Asia-Pacific region is expected to experience rapid growth in the OTC probiotics market, fueled by increasing demand from the expanding urban population and rising disposable incomes.
• North America's Market Leadership: North America holds a significant share of the OTC probiotics supplement market, supported by its established market and health-conscious consumers. The region is also witnessing a growing trend toward targeted OTC probiotic products.

Some of the major players covered in this report include DuPont, Danone, Probi AB, Lifeway Foods, Inc., Kibow Biotech, Pharmavite LLC, Osmotica Pharmaceuticals Corp, Dietary Pros, Inc., and Royal DSM, among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

OTC Probiotics Supplement Market is analyzed into the following segments:

By Form

• Capsules
• Tablets
• Powder & Syrups

By Ingredients

• Bacteria
• Lactobacilli
• Bifidobacterium
• Streptococcus Thermophilus
• Yeast

By Health Area

• Gut Health
• General Health
• Immunity
• Mental Well-Being
• Others

By Distribution Channel

• Online
• Offline

By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Key Findings

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. OTC PROBIOTICS SUPPLEMENT MARKET BY FORM

• 5.1. Introduction
• 5.2. Capsules
• 5.3. Tablets
• 5.4. Powder & Syrups

6. OTC PROBIOTICS SUPPLEMENT MARKET BY INGREDIENTS

• 6.1. Introduction
• 6.2. Bacteria
  • 6.2.1. Lactobacilli
  • 6.2.2. Bifidobacterium
  • 6.2.3. Streptococcus Thermophilus
• 6.3. Yeast

7. OTC PROBIOTICS SUPPLEMENT MARKET BY HEALTH AREA

• 7.1. Introduction
• 7.2. Gut Health
• 7.3. General Health
• 7.4. Immunity
• 7.5. Mental Well-Being
• 7.6. Others

8. OTC PROBIOTICS SUPPLEMENT MARKET BY DISTRIBUTION CHANNEL

• 8.1. Introduction
• 8.2. Online
• 8.3. Offline

9. OTC PROBIOTICS SUPPLEMENT MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Form
  • 9.2.2. By Ingredients
  • 9.2.3. By Health Area
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
    • 9.2.5.1. USA
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. By Form
  • 9.3.2. By Ingredients
  • 9.3.3. By Health Area
  • 9.3.4. By Distribution Channel
  • 9.3.5. By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Others
• 9.4. Europe
  • 9.4.1. By Form
  • 9.4.2. By Ingredients
  • 9.4.3. By Health Area
  • 9.4.4. By Distribution Channel
  • 9.4.5. By Country
    • 9.4.5.1. United Kingdom
    • 9.4.5.2. Germany
    • 9.4.5.3. France
    • 9.4.5.4. Spain
    • 9.4.5.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Form
  • 9.5.2. By Ingredients
  • 9.5.3. By Health Area
  • 9.5.4. By Distribution Channel
  • 9.5.5. By Country
    • 9.5.5.1. Saudi Arabia
    • 9.5.5.2. UAE
    • 9.5.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. By Form
  • 9.6.2. By Ingredients
  • 9.6.3. By Health Area
  • 9.6.4. By Distribution Channel
  • 9.6.5. By Country
    • 9.6.5.1. China
    • 9.6.5.2. Japan
    • 9.6.5.3. India
    • 9.6.5.4. South Korea
    • 9.6.5.5. Taiwan
    • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. DuPont
• 11.2. Danone
• 11.3. Probi AB
• 11.4. Lifeway Foods, Inc.
• 11.5. Kibow Biotech
• 11.6. Pharmavite LLC
• 11.7. Osmotica Pharmaceuticals Corp
• 11.8. Dietary Pros, Inc.
• 11.9. Royal DSM

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations